The Paradigm Shift from Traditional Scientific Platforms to Integrated Communications Plans
In the rapidly evolving biopharma landscape, the approach to scientific communications is undergoing a significant transformation. The shift from traditional scientific platforms to integrated communications plans (ICPs) is becoming increasingly crucial for ensuring cohesive and impactful messaging. This article delves into the components, implementation, and benefits of an ICP tailored for the biopharma industry, addressing the challenges of fragmented messaging and the need for a unified communication strategy...
Read MoreTop Stories
The Paradigm Shift from Traditional Scientific
In the rapidly evolving biopharma landscape, the approach to...
It’s Never Too Soon: How and When to
Engagement with Medical Affairs is critical at every...
Celebrating Health Literacy Month 2024:
October is Health Literacy Month, a reminder of the...
Filter
Periodic Safety Update Report (PSUR): A Breakdown of MDCG 2022-21
A well-structured, clear, and concise PSUR enables a seamless notified body review. Read our key...
A Guide to Creating a Robust Patient Engagement Strategy
Get started on effective patient engagement in your pharmaceutical or biotech company with our comprehensive...
Why Is It Important to Include Patients as Peer Reviewers
Patient peer reviews offer an amazing opportunity to see how HCPs and pharmaceutical companies are...
Clinical Evidence: How Much Is Enough?
Ensuring the safety and functionality of your medical device is vital. But how much clinical...
Medical Device Manufacturing: Risk-Based QMS Alignment for EU MDR
The latest EU-MDR guidelines are a step in the right direction, moving from a focus...
From Transactional to Transformational: Bringing Patient Centricity to the Next Level
The pharma industry’s focus is shifting from the transactional approach to a transformational approach by...